Zobrazeno 1 - 3
of 3
pro vyhledávání: '"R. M. de Voer"'
Autor:
Leonie I. Kroeze, M. van den Heuvel, D. von Rhein, Katrien Grünberg, R. M. de Voer, Erik A. M. Jansen, M.J.L. Ligtenberg, G. Van den Heuvel
Publikováno v:
Annals of Oncology. 31:S1217-S1218
Autor:
M.J.L. Ligtenberg, R. M. de Voer, Nicoline Hoogerbrugge, Marc-Manuel Hahn, Roland P. Kuiper, A. Geurts van Kessel
Publikováno v:
Cellular Oncology (Dordrecht)
Cellular Oncology (2011. Print), 39, 491-510
Cellular Oncology (2011. Print), 39, 6, pp. 491-510
Cellular Oncology (2011. Print), 39, 491-510
Cellular Oncology (2011. Print), 39, 6, pp. 491-510
Contains fulltext : 165806.pdf (Publisher’s version ) (Open Access) BACKGROUND: Colorectal cancer (CRC) is a cumulative term applied to a clinically and genetically heterogeneous group of neoplasms that occur in the bowel. Based on twin studies, up
Autor:
R. M. de Voer, Bart J.M. Vlaminckx, A. Meerveld-Eggink, Douwe H. Biesma, Ger T. Rijkers, O. de Weerdt, Guy A. M. Berbers, H. van Velzen-Blad
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases, 30, 5, pp. 611-8
European Journal of Clinical Microbiology and Infectious Diseases, 30, 611-8
European Journal of Clinical Microbiology and Infectious Diseases, 30, 611-8
The purpose of this study was to determine the quantity and quality of antibodies against the meningococcal serogroup C (MenC) conjugated vaccine in asplenic patients. In 116 asplenic patients, antibody concentrations (IgG) were measured against meni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c9ec649846e966908a9674dc3bcf8d
https://hdl.handle.net/2066/95999
https://hdl.handle.net/2066/95999